Clinical Trial

Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes

Study acronym: CLARA
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A single center, prospective, one arm clinical study to assess the tolerance and effectiveness of total body irradiation and cladribine in adult patients diagnosed with AML( acute myeloid leukemia) and myelodysplastic syndromes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-04-26; most recent amendment 2025-04-21.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-04-21
Trial Details
NCT Number NCT04861207
Lead Sponsor Maria Sklodowska-Curie National Research Institute of Oncology
Collaborators: KCRI
Conditions Acute Myeloid Leukemia Myelodysplastic Syndromes
Enrollment 40 participants
Start Date 2021-10-07
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-24